Skip to main content
. 2020 Jun 29;10:10515. doi: 10.1038/s41598-020-65580-2

Figure 1.

Figure 1

The protective effects of preventative G-CSF treatment on BLM-induced pulmonary fibrosis. (A) Experimental design 1: Preventative treatment with G-CSF (40 µg/kg) was performed daily from day 1 to day 3. Mice were sacrificed, and lung tissues were harvested on day 21 for further testing. (B) The pathological examination of the lung sections utilized H&E staining (upper row) and Masson’s trichrome staining (lower row) (scale bar =100 µm, ×100). (C) The Ashcroft scoring method was used to determine the severity of pulmonary fibrosis. (D) The collagen content was quantified by HYP assay. (E) The mRNA expression levels of collagen I and III were also determined by real-time PCR. n = 4–6. *P < 0.05, **P < 0.01 between the indicated groups. Bars: mean ± SD.